212 results
Search Results
2. Radiomorphometric indices for measuring mandibular bone quality in oncologic patients
3. Pharmacodynamic characterization and evaluation of oxidative stress effects of digitoxigenin derivatives on HeLa cells: Pharmacodynamic characterization and evaluation of oxidative stress effects of digitoxigenin…
4. Systemtherapie von Kopf-Hals-Tumoren – Highlights der ASCO-Jahrestagung 2024
5. Classification of anticancer drugs: an update with FDA- and EMA-approved drugs
6. Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases
7. Arrhythmias in oncological patients: a compact overview for the clinician
8. Preliminary guidelines for the detection and management of drug-related problems in cancer patients with type 2 diabetes mellitus: a practical resource for oncology pharmacists
9. Histone deacetylase inhibitors for leukemia treatment: current status and future directions
10. Kidney function in newly diagnosed myeloma patients: factors associated with kidney impairment and recovery
11. Integrated transcriptomics- and structure-based drug repositioning identifies drugs with proteasome inhibitor properties
12. Chemotherapy’s effects on autophagy in the treatment of Hodgkin’s lymphoma: a scoping review
13. Polypharmacy and drug interactions in older patients with cancer receiving chemotherapy: associated factors
14. Neonatal outcomes and follow-up of children born to women with pregnancy-associated cancer: a prospective observational study
15. Prophylaxe und Therapie Tumortherapie-induzierter Nausea und Emesis: Update der MASCC/ESMO-Leitlinie – was ist neu?
16. The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study
17. Interdisziplinäre Therapie von Hirnmetastasen
18. How to manage the dose of drugs in cancer patients with acute kidney injury, practical recommendations
19. Zielgerichtete Therapie biliärer Tumoren
20. Diagnostik und Therapie der systemischen Mastozytose
21. Screening for clinically relevant drug-drug interactions between direct oral anticoagulants and antineoplastic agents: a pharmacovigilance approach
22. Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents—updated MASCC/ESMO consensus recommendation
23. Emergency department visits among patients receiving systemic cancer treatment in the ambulatory setting
24. Treatment with anticancer drugs for advanced pancreatic cancer: a systematic review
25. Judicialization and cancer: quality of life of patients and caregivers in the COVID-19 pandemic
26. Zielgerichtete Therapie im Rezidiv 1: Hormontherapie – aber nur für wenige Patientinnen
27. Diagnostik und Therapie der systemischen Mastozytose
28. A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancer
29. Management onkologischer Erkrankungen in der Schwangerschaft
30. State of the Art: onkogen alteriertes nichtkleinzelliges Lungenkarzinom im Stadium IV
31. State of the Art: nicht onkogen alteriertes nichtkleinzelliges Lungenkarzinom im Stadium IV
32. Self-care behaviors in patients with cancer treated with oral anticancer agents: a systematic review
33. Behandlung des nodulär Lymphozyten-prädominanten Hodgkin Lymphoms
34. Patient-reported outcomes during repetitive oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for isolated unresectable colorectal peritoneal metastases in a multicenter, single-arm, phase 2 trial (CRC-PIPAC)
35. HIV-assoziierte Neoplasien
36. Chemotherapie und zielgerichtete Therapie von Kopf-Hals-Plattenepithelkarzinomen beim ASCO-Kongress 2021
37. Aktuelle Diagnostik und systemische Therapie des hepatozellulären Karzinoms: Surveillance, Diagnostik und Strategien in der Sequenztherapie
38. The influence of antineoplastic agents on the peri-implant bone around osseointegrated titanium implants: an in vivo histomorphometric and immunohistochemical study
39. Influence of the treatment with the antineoplastic agents 5-fluorouracil and cisplatin on the severity of experimental periodontitis in rats
40. Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials
41. Physical rehabilitation for the management of cancer-related fatigue during cytotoxic treatment: a systematic review with meta-analysis
42. Systemic oncological treatments in patients with advanced pancreatic cancer: a scoping review and evidence map
43. Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204
44. Judicialization of health: profile of demands for oncological medicines in a state in the central region of Brazil
45. Public procurement of antineoplastic agents used for treating breast cancer in Brazil between 2013 and 2019
46. Oral lichenoid lesion in association with chemotherapy treatment for non-Hodgkin lymphoma or lichen planus? Review of the literature and report of two challenging cases
47. Oxaliplatin- versus cisplatin-based regimens for elderly individuals with advanced gastric cancer: a retrospective cohort study
48. Antineoplastic agents aggravate the damages caused by nicotine on the peri-implant bone: an in vivo histomorphometric and immunohistochemical study in rats
49. Risk factors for dysgeusia during chemotherapy for solid tumors: a retrospective cross-sectional study
50. Entwicklung von Onkologika in der Pharma- und Biotechindustrie in Deutschland
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.